BioSpace News Archive

Albany NY, United States: Penile implant is a medical device which is implanted within the corpora cavernosa of the penis through a surgical procedure.

BerGenBio ASA, a clinical-stage biopharmaceutical company developing novel, selective AXL inhibitors for severe unmet medical needs, announces an update on its business strategy.

G1 Therapeutics, Inc., a commercial-stage oncology company, provided a corporate and financial update for the first quarter ended March 31, 2022.

Bio-Techne Corporation reported its financial results for the third quarter ended March 31, 2022.

IVERIC Bio, Inc. announced that a post-hoc analysis evaluating the reduction in geographic atrophy lesion growth observed in patients receiving Zimura® as compared to patients receiving sham in the completed GATHER1 clinical trial will be presented at the upcoming Retinal World Congress in Fort Lauderdale, FL on May 13, 2022.

Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2022 financial results.

Oncolytics Biotech® Inc. and SOLTI-Innovative Cancer Research today announced new clinical biomarker data demonstrating pelareorep’s immunotherapeutic effects, synergy with checkpoint inhibition, and potential to improve the outlook for patients with HR+/HER2- breast cancer.

Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today reported first quarter 2022 financial results and provided business updates.

Retinitis pigmentosa, is a condition where patients typically loses ability to see at night in young years, side vision in middle age, and focal vision in later in his/her life due to relentless loss of cone photoreceptor cells.

argenx announced that members of management will participate in a fireside chat at the BofA Securities 2022 Healthcare Conference on Wednesday, May 11, 2022 at 10:40 a.m. P.T. in Las Vegas, NV.